Literature DB >> 6595096

Urinary prostaglandins in sickle cell nephropathy: a defect in 9-ketoreductase activity?

P E de Jong, A W Saleh, D de Zeeuw, A J Donker, G K van der Hem, J J Pratt, G S Sewrajsingh, L W Statius van Eps.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6595096

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN： 0301-0430            Impact factor:   0.975


× No keyword cloud information.
  5 in total

Review 1.  Sickle cell nephropathy: challenging the conventional wisdom.

Authors:  Amy M Becker
Journal:  Pediatr Nephrol       Date:  2011-01-04       Impact factor: 3.714

Review 2.  Renal complications of sickle cell disease: managing for optimal outcomes.

Authors:  Luciana de Santis Feltran; João Thomás de Abreu Carvalhaes; Ricardo Sesso
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 3.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

4.  Severe anemia: a risk factor for glomerular injury in sickle cell disease.

Authors:  M Faulkner; E A Turner; J Deus; K Phillips; C Weaver; O Taiwo; O Omitowoju
Journal:  J Natl Med Assoc       Date:  1995-03       Impact factor: 1.798

5.  Relating retinal blood flow and vessel morphology in sickle cell retinopathy.

Authors:  Jennifer Cano; Shayan Farzad; Maziyar M Khansari; Ou Tan; David Huang; Jennifer I Lim; Mahnaz Shahidi
Journal:  Eye (Lond)       Date:  2019-09-26       Impact factor: 3.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.